Squarepoint Ops LLC Gossamer Bio, Inc. Transaction History

Squarepoint Ops LLC

  • $80.7 Billion
  • Q1 2025

A detailed history of Squarepoint Ops LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 217,921 shares of GOSS stock, worth $252,788. This represents 0.0% of its overall portfolio holdings.

Number of Shares
217,921
Previous 71,944 202.9%
Holding current value
$252,788
Previous $64,000 273.44%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.85 - $1.53 $124,080 - $223,344
145,977 Added 202.9%
217,921 $239,000
Q4 2024

Feb 14, 2025
SELL
$0.66 - $1.07 $49,508 - $80,263
-75,013 Reduced 51.04%
71,944 $64,000
Q3 2024

Nov 14, 2024
BUY
$0.79 - $1.25 $116,096 - $183,696
146,957 New
146,957 $145,000
Q1 2024

May 15, 2024
BUY
$0.8 - $1.51 $202,874 - $382,925
253,593 Added 546.05%
300,034 $354,000
Q4 2023

Feb 14, 2024
SELL
$0.48 - $1.08 $49,738 - $111,911
-103,622 Reduced 69.05%
46,441 $42,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $499,664 - $780,088
-509,862 Reduced 77.26%
150,063 $180,000
Q1 2023

May 15, 2023
SELL
$0.96 - $2.92 $244,800 - $744,602
-255,001 Reduced 27.87%
659,925 $831,000
Q4 2022

Feb 14, 2023
BUY
$1.74 - $12.87 $1.17 Million - $8.68 Million
674,380 Added 280.35%
914,926 $1.99 Million
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $1.5 Million - $3.09 Million
207,985 Added 638.75%
240,546 $2.88 Million
Q2 2022

Aug 15, 2022
SELL
$5.97 - $9.97 $108,570 - $181,314
-18,186 Reduced 35.84%
32,561 $273,000
Q1 2022

May 16, 2022
BUY
$8.44 - $12.49 $428,304 - $633,830
50,747 New
50,747 $440,000
Q3 2021

Nov 15, 2021
SELL
$7.25 - $13.23 $76,668 - $139,907
-10,575 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$8.0 - $9.75 $156,904 - $191,226
-19,613 Reduced 64.97%
10,575 $86,000
Q1 2021

May 17, 2021
SELL
$8.63 - $10.94 $206,507 - $261,783
-23,929 Reduced 44.22%
30,188 $279,000
Q4 2020

Feb 16, 2021
BUY
$8.3 - $13.59 $330,597 - $541,303
39,831 Added 278.81%
54,117 $523,000
Q3 2020

Nov 16, 2020
BUY
$11.3 - $14.75 $4,440 - $5,796
393 Added 2.83%
14,286 $177,000
Q2 2020

Aug 14, 2020
SELL
$9.52 - $15.98 $42,173 - $70,791
-4,430 Reduced 24.18%
13,893 $181,000
Q1 2020

May 15, 2020
SELL
$8.0 - $15.48 $120,912 - $233,964
-15,114 Reduced 45.2%
18,323 $186,000
Q4 2019

Feb 14, 2020
BUY
$14.82 - $26.79 $495,536 - $895,777
33,437 New
33,437 $523,000

Others Institutions Holding GOSS

# of Institutions
127
Shares Held
162M
Call Options Held
2.11M
Put Options Held
57.8K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $109M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email